vVARDIS Completes Initial Public Offering on the NYSE
Swiss dental technology company vVARDIS (NYSE: VVVV) has officially listed on the New York Stock Exchange. The company focuses on non-invasive dental care, specifically targeting early-stage tooth decay through its proprietary peptide technology designed to support enamel remineralization. The company's flagship product, Curodont® Repair Fluoride Plus, offers a drill-free and needle-free alternative to traditional fillings. vVARDIS aims to address the global dental health crisis, noting that billions of people suffer from untreated decay and many avoid treatment due to dental anxiety.
Topics: Dental Technology IPO NYSE Listing Public Offering
Read the full article at PR Newswire
Part of the story Anthropic Announces Initial Public Offering Scheduled for November 19 (15 articles)